MedWatch

Novo CEO condemns invasion of Ukraine – but keeps Russian factory running

Despite the invasion of Ukraine, pharmaceutical firm Novo Nordisk keeps the operations of its factory in Russia running. Employees in Ukraine have gone unharmed, the company also reports.

Lars Fruergaard Jørgensen, CEO of Novo Nordisk | Photo: Stine Bidstrup/ERH

CEO of Novo Nordisk Lars Fruergaard Jørgensen has for the first time commented directly on Russia’s invasion of Ukraine – which he is firmly against, it should come as no surprise.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs